Company Overview of Advanced Accelerator Applications SA
Advanced Accelerator Applications SA is engaged in the research, development, production, and distribution of molecular imaging and molecular therapy products. It offers positron emission tomography (PET) and single photon emission tomography radiopharmaceuticals for molecular diagnostics and therapy. The company provides Fluoro Deoxy Glucose that is used to assess glucose metabolism in the brain, including Alzheimer’s disease, dementia, epilepsy, brain trauma, Huntington disease, cerebrovascular disorders, brain tumors, schizophrenia, and mood disorders; cancer, including lung, colorectal, esophageal, head and neck, breast and thyroid carcinoma, melanoma, and lymphoma; cardiovascular diseas...
20 Rue Diesel
Saint Genis Pouilly, 01630
Founded in 2002
Key Executives for Advanced Accelerator Applications SA
Group Chief Financial Officer and Director
Chief Operating Officer and Director
Head of Clinical Development
Compensation as of Fiscal Year 2014.
Advanced Accelerator Applications SA Key Developments
Advanced Accelerator Applications SA Announces Earnings Results for the Full Year Ended December 31, 2013
Jul 10 14
Advanced Accelerator Applications SA announced earnings results for the full year ended December 31, 2013. For the period, the company reported net loss for the year from continuing operations of EUR 9,861,000 compared with EUR 16,912,000 for the same period a year ago. EBITDA was EUR 10,638,000 compared with EUR 6,577,000 for the same period a year ago. Sales for the year increased by 31.77% to EUR 53.8 million compared with EUR 40.8 million for the same period a year ago.
Advanced Accelerator Applications SA Appoints Kapil Dhingra as Independent Non-Executive Director
Apr 29 14
Advanced Accelerator Applications S.A. announced that Dr. Kapil Dhingra has joined the company Board of Directors as an Independent Non-Executive Director. Dr. Dhingra has over 25 year's experience in oncology clinical research and drug development, including nine years at Roche Pharmaceuticals, where he played a key role in the expansion of Roche Oncology. From 1999 to 2008 he served in positions of increasing responsibility at Roche, including Vice President, Head, Oncology Disease Biology Leadership Team, and Head, Oncology Clinical Development. Prior to his time at Roche, Dr. Dhingra worked in the oncology clinical development group at Eli Lilly and Company. He has also previously served as a Clinical Instructor, Assistant Professor of Medicine at the University of Texas M.D. Anderson Cancer Center. Dr. Dhingra holds an M.B.,B.S. (equivalent to a U.S. M.D.) degree from the All India Institute of Medical Sciences. He is Board-certified in Internal Medicine and Medical Oncology.
Advanced Accelerator Applications SA Presents at UBS Global Healthcare Conference, May-19-2014 04:00 PM
Mar 19 14
Advanced Accelerator Applications SA Presents at UBS Global Healthcare Conference, May-19-2014 04:00 PM. Venue: Sheraton New York Times Square Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Stefano Buono, Founder, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions